Literature DB >> 6179053

The ventricular paced QT interval--the effects of rate and exercise.

J R Milne, D E Ward, R A Spurrell, A J Camm.   

Abstract

Changes in the QT and QTc intervals in 19 patients were studied at a ventricular paced rate difference of 50 beats/min. In all patients the measured QT interval shortened as the pacing rate was increased, from a mean value of 441 ms to 380 ms (p less than 0.001), but when corrected for heart rate the QTc lengthened from a mean value of 518 ms to 575 ms. In 11 patients the QT interval was measured at rest and immediately following exercise sufficient to increase the atrial rate by approximately 50 beats/min at identical ventricular paced rates. In all patients exercise-induced QT interval shortening from a mean value of 433 ms to 399 ms (p less than 0.001). These results show first that Bazett's formula is unsuitable for correction of QT interval induced by ventricular pacing, and second that heart rate and changes in sympathetic tone independently influence the duration of the QT interval. It is suggested that these results are relevant to the design of physiological pacemakers in which the duration of the QT interval influences the discharge frequency of the pacemaker and to the consideration of ventricular pacing for the treatment of abnormal repolarization syndromes.

Entities:  

Mesh:

Year:  1982        PMID: 6179053     DOI: 10.1111/j.1540-8159.1982.tb02242.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  10 in total

1.  Lack of correlation between exercise and sibenadet-induced changes in heart rate corrected measurement of the QT interval.

Authors:  Paul Newbold; Nick Sanders; Stots B Reele
Journal:  Br J Clin Pharmacol       Date:  2006-09-12       Impact factor: 4.335

2.  QT dynamics early after exercise as a predictor of mortality.

Authors:  Nils P Johnson; Thomas A Holly; Jeffrey J Goldberger
Journal:  Heart Rhythm       Date:  2010-05-15       Impact factor: 6.343

3.  Assessment of frequency dependency of the class III effects of almokalant: a study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervals.

Authors:  B Darpö; O Almgren; R Bergstrand; S Franzén; N Edvardsson
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

4.  Heart rate and catecholamine contribution to QT interval shortening on exercise.

Authors:  P Davey; J Bateman
Journal:  Clin Cardiol       Date:  1999-08       Impact factor: 2.882

5.  An Improved QT Correction Method for use in Atrial Fibrillation and a Comparison with the Assessment of QT in Sinus Rhythm.

Authors:  Deepak Saluja; Jason A Guyotte; James A Reiffel
Journal:  J Atr Fibrillation       Date:  2008-05-16

6.  Polymorphic ventricular tachycardia in acute myocardial infarction treated by thrombolysis: reperfusion, complication or iatrogenic sign?

Authors:  Mariana Floria; Ciprian Rezus; Mirela Ciutea; Eva Orban; Iuliana Marian; Lacramioara Pantaru; Valentin Ambarus
Journal:  Maedica (Buchar)       Date:  2010-04

7.  Dynamics of ventricular repolarisation in the congenital long QT syndromes.

Authors:  N J Linker; A J Camm; D E Ward
Journal:  Br Heart J       Date:  1991-09

8.  Predictive Power of f99 Repolarization Index for the Occurrence of Ventricular Arrhythmias.

Authors:  Corrado Giuliani; Cees A Swenne; Sumche Man; Angela Agostinelli; Sandro Fioretti; Francesco Di Nardo; Laura Burattini
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-11-25       Impact factor: 1.468

9.  QTc prolongation assessment in anticancer drug development: clinical and methodological issues.

Authors:  G Curigliano; G Spitaleri; F de Braud; D Cardinale; C Cipolla; M Civelli; N Colombo; A Colombo; M Locatelli; A Goldhirsch
Journal:  Ecancermedicalscience       Date:  2009-01-12

10.  Value of the New Spline QTc Formula in Adjusting for Pacing-Induced Changes in Heart Rate.

Authors:  Hirmand Nouraei; Matthew Bennett; Simon Rabkin
Journal:  Cardiol Res Pract       Date:  2018-04-01       Impact factor: 1.866

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.